Glossary

biotechnological weapon or bioweapon: “Microbial or other biological agents, or toxins whatever their origin or method of production, of types and in quantities that have no justification for prophylactic, protective or other peaceful purposes; Weapons, equipment or means of delivery designed to use such agents or toxins for hostile purposes or in armed conflict “(1).

Tags: 

(Also known as germ warfare) The use of biological toxins or infectious agents such as

bacteria, viruses, and fungi with intent to kill or incapacitate humans, animals or plants

as an act of war.

Tags: 

Processes of organic origin or those conveyed by biological vectors, including

exposure to pathogenic micro-organisms, toxins and bioactive substances, which may

cause the loss of life or injury, property damage, social and economic disruption or

environmental degradation. Examples of biological hazards include outbreaks of

epidemic diseases, plant or animal contagion, insect or other animal plagues and

extensive infestations.

Tags: 

Disaster caused by the exposure of living organisms to germs and toxic substances.

(UN DHA)

Tags: 

“Biological threat agents are microorganisms such as bacteria, rickettsia, fungi, viruses and toxins, that cause infections leading to incapacitation or death of people, domestic animals and/or destruction of crop plants.”(1)

Biological agents are not biological weapons. Merely possessing biological agents with the theoretical potential to cause harm is insufficient; the toxins or microorganisms need to be “weaponized”, i.e. prepared and disseminated effectively to their target.”(2)

 

(1) FFI FACTS

(2) Ackerman, G.A. and Moran, K.S. (2006), p.3

Tags: 

Biological attack is the intentional release of a pathogen (disease causing agent) or biotoxin (poisonous substance produced by a living organism) against humans, plants, or animals. An attack against people could be used to cause illness, death, fear, societal disruption, and economic damage. An attack on agricultural plants and animals would primarily cause economic damage, loss of confidence in the food supply, and possible loss of life. It is useful to distinguish between two kinds of biological agents:

Tags: 

А systematic deviation of results or inferences from the truth or processes leading to

such systematic deviation; any systematic tendency in the collection, analysis,

interpretation, publication, or review of data that can lead to conclusions that are

systematically different from the truth. In epidemiology, does not imply intentional

deviation.

 

Tags: 

A best practice is a method or technique that has consistently shown results superior

to those achieved with other means, and that is used as a benchmark.

Best practices should demonstrate a positive and tangible impact on improving the

living environment of people, should be based on partnership between the public,

private and civil society sectors and should be socially, economically and

environmentally sustainable. (1)

 

(1) United Nations Economic and Social Council, Definition of basic concepts and

Tags: 

A concept in research ethics which states that researchers should have the welfare of

the research participant as a goal of any clinical trial. The antonym of this term,

maleficence, describes a practice which opposes the welfare of any research

participant. The concept that medical professionals and researchers would always

practice beneficence seems natural to most patients and research participants, but in

fact, every health intervention or research intervention has potential to harm the

Tags: 

An expectation about the way some event or sequence of events will occur. Conviction

or confidence in the truth of some-thing that is not based on absolute proof. (1)

 

(1) Glossary of communication, University of Jyväskylä

Tags: 

Pages

Subscribe to Glossary

MMLAP and other EU Projects

Health system analysis to support capacity development in response to the threat of pandemic influenza in Asia
Making society an active participant in water adaptation to global change
Public Participation in Developing a Common Framework for Assessment and Management of Sustainable Innovation
Engaging all of Europe in shaping a desirable and sustainable future
Expect the unexpected and know how to respond
Driving innovation in crisis management for European resilience
Effective communication in outbreak management: development of an evidence-based tool for Europe
Solutions to improve CBRNe resilience
Network for Communicable Disease Control in Southern Europe and Mediterranean Countries
Developing the framework for an epidemic forecast infrastructure
Strengthening of the national surveillance system for communicable diseases
Surveillance of vaccine preventable hepatitis
European monitoring of excess mortality for public health action
European network for highly infectious disease
Dedicated surveillance network for surveillance and control of vaccine preventable diseases in the EU
Modelling the spread of pandemic influenza and strategies for its containment and mitigation
Cost-effectiveness assessment of european influenza human pandemic alert and response strategies
Bridging the gap between science, stakeholders and policy makers
Promotion of immunization for health professionals in Europe
Towards inclusive research programming for sustainable food innovations
Addressing chronic diseases and healthy ageing across the life cycle
Medical ecosystem – personalized event-based surveillance
Studying the many and varied economic, social, legal and ethical aspects of the recent developments on the Internet, and their consequences for the individual and society at large
Get involved in the responsible marine research and innovation
Knowledge-based policy-making on issues involving science, technology and innovation, mainly based upon the practices in Parliamentary Technology Assessment
Assessment of the current pandemic preparedness and response tools, systems and practice at national, EU and global level in priority areas
Analysis of innovative public engagement tools and instruments for dynamic governance in the field of Science in Society
Public Engagement with Research And Research Engagement with Society
Computing Veracity – the Fourth Challenge of Big Data
Providing infrastructure, co-ordination and integration of existing clinical research networks on epidemics and pandemics
Promote vaccinations among migrant population in Europe
Creating mechanisms for effectively tackling the scientific and technology related challenges faced by society
Improve the quality of indoor air, keeping it free from radon
Improving respect of ethics principles and laws in research and innovation, in line with the evolution of technologies and societal concerns
Investigating how cities in the West securitise against global pandemics
Creating a structured dialogue and mutual learning with citizens and urban actors by setting up National Networks in 10 countries across Europe
Identifying how children can be change agents in the Science and Society relationship
Establishing an open dialogue between stakeholders concerning synthetic biology’s potential benefits and risks
Transparent communication in Epidemics: Learning Lessons from experience, delivering effective Messages, providing Evidence